TMCC2 and Alzheimer disease: Further limitations include being unable to stratify our data according to post‐mortem delay and that, by necessity, studies using human post‐mortem tissue are observational in nature, which precludes definitive inferences as to the mechanism(s) by which TMCC2 might influence AD pathogenesis.